Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Dec 15, 2020; 12(12): 1456-1463
Published online Dec 15, 2020. doi: 10.4251/wjgo.v12.i12.1456
Published online Dec 15, 2020. doi: 10.4251/wjgo.v12.i12.1456
Figure 3 18F-fluoro-D-glucose positron emission tomography/X-ray computed tomography performed after eight courses of FOLFIRINOX.
A and B: 18F-fluoro-D-glucose positron emission tomography/X-ray computed tomography shows a metabolic reduction in cephalopancreatic disease.
- Citation: Di Marco M, Carloni R, De Lorenzo S, Mosconi C, Palloni A, Grassi E, Filippini DM, Ricci AD, Rizzo A, Di Federico A, Santini D, Turchetti D, Ricci C, Ingaldi C, Alberici L, Minni F, Golfieri R, Brandi G, Casadei R. Pancreatic mucinous cystadenocarcinoma in a patient harbouring BRCA1 germline mutation effectively treated with olaparib: A case report. World J Gastrointest Oncol 2020; 12(12): 1456-1463
- URL: https://www.wjgnet.com/1948-5204/full/v12/i12/1456.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i12.1456